RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Eurofins Scientific Stock

Eurofins Scientific Stocks 2024

Eurofins Scientific Stocks

197.9 M

Ticker

ERF.PA

ISIN

FR0014000MR3

WKN

A2QJCT

In 2024, Eurofins Scientific had 197.9 M outstanding stocks, a 0% change from the 197.9 M stocks in the previous year.

The Eurofins Scientific Stocks history

YEARNUMBER OF STOCKS (undefined EUR)
2028e197.9
2027e197.9
2026e197.9
2025e197.9
2024e197.9
2023197.9
2022199
2021200.6
2020195.9
2019186
2018183.01
2017179.98
2016169.57
2015162.66
2014160.6
2013159.94
2012158.06
2011156.84
2010148.59
2009141.83
2008151.78
2007150.77
2006149.39
2005143.91
2004141.24

Eurofins Scientific shares outstanding

The number of shares was Eurofins Scientific in 2023 — This indicates how many shares 197.9 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Eurofins Scientific earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Eurofins Scientific's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Eurofins Scientific’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Eurofins Scientific's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Eurofins Scientific Aktienanalyse

What does Eurofins Scientific do?

Eurofins Scientific SE is a leading group of laboratories specializing in providing testing and analytical services for the food, environment, pharmaceutical, and biopharmaceutical industries. The company was founded in 1987 by Dr. Gilles Martin and is headquartered in Luxembourg. It has since become one of the largest laboratory service providers worldwide. Eurofins' business model is based on a wide range of analytical services that enable customers to monitor product quality, process safety, and regulatory compliance. Eurofins offers a comprehensive range of tests, including food and feed testing, residue analysis, hygiene and contamination analysis, environmental analysis, and genetic testing. The group operates more than 800 laboratories in 47 countries and employs more than 50,000 people. Eurofins has a strong presence in Europe, North America, and the Asia-Pacific region, and is active in various industries such as agriculture and food, environment and pharmaceuticals, as well as clinical diagnostics and forensics. The different divisions of Eurofins are tailored to the specific needs of its customers. For example, the "Food Testing" division offers a wide range of tests to ensure that food is safe and healthy. Thanks to these tests, manufacturers can ensure that their products comply with legal requirements and meet customer needs. Another division of Eurofins is "Environment Testing," which offers tests and analyses for a variety of environmental samples. These enable companies to monitor compliance with environmental regulations, identify environmental issues, and improve their environmental footprint. Eurofins' Biopharma division offers a variety of testing services for the biopharmaceutical industry, including clearance studies, cleaning validation, particle measurements, and DNA sequencing. In the field of clinical diagnostics, Eurofins provides laboratory services to improve diagnoses and treatments. These include genetic testing, oncology tests, prenatal diagnostics, and infectious diseases. Another important business area for Eurofins is forensics, which benefits from the latest developments in DNA analysis as well as analysis methods for detecting drugs, alcohol, and toxic substances. The services provided by Eurofins include forensic wildlife investigations and the identification of human and animal species based on DNA samples. In addition to the aforementioned business areas, Eurofins also offers a wide range of services such as consulting, audits, and training to help improve its customers' performance and help them achieve their business goals. In conclusion, Eurofins Scientific SE is a leading provider of testing and analytical services for the food, environment, pharmaceutical, and biopharmaceutical industries. With its specialized services, the company enables its customers to monitor product quality, process safety, and regulatory compliance. Eurofins' various divisions offer tests and analyses for a variety of industries, contributing to improving its customers' businesses. Eurofins Scientific ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Eurofins Scientific's Shares Outstanding

Eurofins Scientific's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Eurofins Scientific’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Eurofins Scientific’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Eurofins Scientific’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Eurofins Scientific stock

How many stocks are there of Eurofins Scientific?

The current number of stocks of Eurofins Scientific is 197.9 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Eurofins Scientific are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Eurofins Scientific evolved in recent years?

The number of shares of Eurofins Scientific has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Eurofins Scientific as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Eurofins Scientific?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Eurofins Scientific pay?

Over the past 12 months, Eurofins Scientific paid a dividend of 1 EUR . This corresponds to a dividend yield of about 2.13 %. For the coming 12 months, Eurofins Scientific is expected to pay a dividend of 1.09 EUR.

What is the dividend yield of Eurofins Scientific?

The current dividend yield of Eurofins Scientific is 2.13 %.

When does Eurofins Scientific pay dividends?

Eurofins Scientific pays a quarterly dividend. This is distributed in the months of August, August, August, August.

How secure is the dividend of Eurofins Scientific?

Eurofins Scientific paid dividends every year for the past 8 years.

What is the dividend of Eurofins Scientific?

For the upcoming 12 months, dividends amounting to 1.09 EUR are expected. This corresponds to a dividend yield of 2.31 %.

In which sector is Eurofins Scientific located?

Eurofins Scientific is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eurofins Scientific kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eurofins Scientific from 7/5/2024 amounting to 0.5 EUR, you needed to have the stock in your portfolio before the ex-date on 7/3/2024.

When did Eurofins Scientific pay the last dividend?

The last dividend was paid out on 7/5/2024.

What was the dividend of Eurofins Scientific in the year 2023?

In the year 2023, Eurofins Scientific distributed 1 EUR as dividends.

In which currency does Eurofins Scientific pay out the dividend?

The dividends of Eurofins Scientific are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Eurofins Scientific

Our stock analysis for Eurofins Scientific Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Eurofins Scientific Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.